GDP drug
Evidence from:
primary |
all sources
Related entities (6)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| DAMGO | associated_with | GDP | — | 1 |
| GDP | associated_with | EGTA | — | 1 |
| GDP | associated_with | MgCl2 | — | 1 |
| GDP | associated_with | negative consequences | — | 1 |
| GDP | associated_with | Tris-HCl | — | 1 |
| usual quantity | interacts_with | GDP | — | 1 |
Mentioned in (12)
Papers in which this entity is mentioned.
- Regulation of mTORC1 by PI3K signaling. (2015)
- Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPγS binding in mice with Oprm1 A112G. (2014)
- Ethanol exposure induces neonatal neurodegeneration by enhancing CB1R Exon1 histone H4K8 acetylation and up-regulating CB1R function causing neurobehavioral abnormalities in adult mice. (2014)
- Cancer genome landscapes. (2013)
- Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors. (2013)
- Synaptic effects induced by alcohol. (2013)
- Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity. (2012)
- Receptor heteromerization expands the repertoire of cannabinoid signaling in rodent neurons. (2012)
- A genetic determinant of the striatal dopamine response to alcohol in men. (2011)
- AT1R-CB₁R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II. (2011)
- Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor. (1997)
- Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain. (1996)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| gdp | drug | 12 | 23 |
| guanosine diphosphate | drug | — | — |